The Scientist

» European Commission and immunology

Most Recent

image: Novel Hantavirus Infection Method

Novel Hantavirus Infection Method

By | July 3, 2015

Researchers find that the potentially deadly virus uses cholesterol to gain access to cells.

0 Comments

image: Brrrr-ying the Results

Brrrr-ying the Results

By | July 1, 2015

Holding laboratory mice at temperatures lower than those the animals prefer could be altering their physiology and skewing experimental results.

1 Comment

image: Diagnosing Ebola in 15 Minutes

Diagnosing Ebola in 15 Minutes

By | June 30, 2015

A new test that scans for the Ebola virus with just a fingerprick could be a practical diagnostic for use in West Africa.

0 Comments

image: Sex Differences in Pain Pathway

Sex Differences in Pain Pathway

By | June 29, 2015

Male and female mice utilize different immune cells to process pain, a study shows.

1 Comment

image: Neutralizing HIV

Neutralizing HIV

By | June 18, 2015

Engineered immunogens based on conserved patches of the virus’s envelope protein point to new strategies for vaccine design.

0 Comments

image: Brain Drain

Brain Drain

By | June 1, 2015

The brain contains lymphatic vessels similar to those found elsewhere in the body, a mouse study shows.

3 Comments

image: New Immunity

New Immunity

By | June 1, 2015

A scaffolding protein forms the hub of a newly identified immune pathway in plants.

0 Comments

image: EC Gets Science Panel

EC Gets Science Panel

By | May 14, 2015

The European Commission unveils a plan to install a team of science advisors to guide policymakers.

0 Comments

image: Measles Vax’s Off-Target Effects

Measles Vax’s Off-Target Effects

By | May 11, 2015

Researchers find evidence that measles vaccines reduced deaths from other infectious diseases due to “immune amnesia.”

2 Comments

image: Outsmarting HIV

Outsmarting HIV

By | May 4, 2015

Small molecules that mimic the T-cell surface receptor CD4 could expose the virus to antibody-based immune responses.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham